New treatment option for Stroke
Official title Effects of Intermitted Theta Burst Stimulation (iTBS) on Motor Recovery of Upper Extremity in Chronic Stroke Patients
ClinicalTrials.gov ID: NCT07073248
What this study is testing
- What it's testing
- This study aims to evaluate the effects and clinical feasibility of non-invasive brain stimulation protocols, specifically intermittent Theta Burst Stimulation, as part of rehabilitation interventions for motor recovery of upper extremity in the chronic phase after stroke. It also seeks to explore the underlying mechanisms by investigating changes of functional and structural brain networks.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age over 18
- Chronic stroke (\>6 months)
- Residual hemiparesis FM-UE\>17
You likely can't join if
- Metal implants
- Epilepsy/seizures
- Pregnancy
- Claustrophobia (related to MRIs exams)
- Severe cognitive impairment
- Untreated or unstable depression/anxiety
See the full eligibility criteria
- Age over 18
- Chronic stroke (\>6 months)
- Residual hemiparesis FM-UE\>17
- Metal implants
- Epilepsy/seizures
- Pregnancy
- Claustrophobia (related to MRIs exams)
- Severe cognitive impairment
- Untreated or unstable depression/anxiety
- Other disabilities prohibiting intensive physical training
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.